NEW YORK (GenomeWeb News) – KeyGene and Floragenex today said that they have agreed to end a legal dispute and have entered into a licensing agreement covering sequence-based genotyping technology.

KeyGene had filed the patent infringement suit against Floragenex last year in the US District Court for the District of Orgeon.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.